1,25-Dihydroxyvitamin D and the Vitamin D Receptor Gene Polymorphism Apa1 Influence Bone Mineral Density in Primary Hyperparathyroidism

作者: Monika H. E. Christensen , Ellen M. Apalset , Yngve Nordbø , Jan Erik Varhaug , Gunnar Mellgren

DOI: 10.1371/JOURNAL.PONE.0056019

关键词:

摘要: Objective Parathyroid hormone (PTH) and vitamin D are the most important hormones regulating calcium metabolism. In primary hyperparathyroidism (PHPT) excessive amounts of PTH produced. Bone turnover is enhanced, leading to reduced bone mineral density elevated levels serum calcium. The aim this study was investigate relations between 25-hydroxyvitamin (25(OH)D), 1,25-dihydroxyvitamin (1,25(OH)2D) density, as well known genetic polymorphisms in receptor enzymes metabolising patients with PHPT. Design/Subjects We conducted a cross-sectional 52 PHPT. Results Mean level 25(OH)D 58.2 nmol/L median 1,25(OH)2D 157 pmol/L. Among our PHPT 36.5% had below 50 nmol/L. Serum inversely correlated distal radius (p = 0.002), but not at lumbar spine or femoral neck. polymorphism Apa1 (rs7975232) associated spine. Conclusions The results suggest that high blood concentrations may have deleterious skeletal effects. Randomized, prospective studies necessary elucidate whether supplementation additionally increases possibly enhances adverse effects on skeleton PHPT.

参考文章(49)
Heike A. Bischoff-Ferrari, Optimal Serum 25-Hydroxyvitamin D Levels for Multiple Health Outcomes Advances in Experimental Medicine and Biology. ,vol. 624, pp. 55- 71 ,(2008) , 10.1007/978-0-387-77574-6_5
Heather B Del Valle, A Catharine Ross, Ann L Yaktine, Christine L Taylor, Dietary Reference Intakes for Calcium and Vitamin D ,(2013)
Katsuhisa Tashiro, Takaya Abe, Naohide Oue, Wataru Yasui, Masaru Ryoji, Characterization of vitamin D-mediated induction of the CYP 24 transcription. Molecular and Cellular Endocrinology. ,vol. 226, pp. 27- 32 ,(2004) , 10.1016/J.MCE.2004.07.012
Glenville Jones, David E. Prosser, Martin Kaufmann, 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Archives of Biochemistry and Biophysics. ,vol. 523, pp. 9- 18 ,(2012) , 10.1016/J.ABB.2011.11.003
P. Christiansen, T. Steiniche, H. Brockstedt, L. Mosekilde, I. Hessov, F. Melsen, Primary hyperparathyroidism: Iliac crest cortical thickness, structure and remodeling evaluated by histomorphometric methods Bone. ,vol. 14, pp. 755- 762 ,(1993) , 10.1016/8756-3282(93)90207-Q
J. Bollerslev, J. Gram, H.K. Nielsen, K. Brixen, T. Storm, H.F. Larsen, L. Mosekilde, Effect of a short course of 1,25-dihydroxyvitamin D3 on biochemical markers of bone remodeling in adult male volunteers. Bone. ,vol. 12, pp. 339- 343 ,(1991) , 10.1016/8756-3282(91)90020-J
L. Mosekilde, P. Charles, P. Lindegreen, Determinants for serum 1,25-dihydroxycholecalciferol in primary hyperparathyroidism. Bone and Mineral. ,vol. 5, pp. 279- 290 ,(1989) , 10.1016/0169-6009(89)90006-8
Tatsuo Suda, Yutaka Ueno, Katsuyuki Fujii, Toshimasa Shinki, Vitamin D and bone Journal of Cellular Biochemistry. ,vol. 88, pp. 259- 266 ,(2003) , 10.1002/JCB.10331
Monika H. E. Christensen, Ernst A. Lien, Steinar Hustad, Bjørg Almås, Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway Scandinavian Journal of Clinical & Laboratory Investigation. ,vol. 70, pp. 281- 286 ,(2010) , 10.3109/00365511003797172